Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
- PMID: 20010944
- PMCID: PMC2816658
- DOI: 10.1038/sj.bjc.6605488
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
Abstract
Background: Putative breast cancer stem cells might express surface markers such as aldehyde dehydrogenase 1 (ALDH1) and BMI-1 proteins. The aim of this study was to explore the expression of these proteins in breast cancers from an African population and their associations with the basal-like phenotype (BLP) and other molecular characteristics.
Methods: We analysed 192 paraffin-embedded breast carcinoma samples by tissue microarrays and immunohistochemical methods.
Results: In total, 88 tumours (48%) expressed ALDH1, whereas 46 (25%) expressed BMI-1 protein. Expression of ALDH1 was associated with high histological grade (P<0.0005), high mitotic count (P<0.0005), high nuclear grade (P<0.0005), oestrogen receptor (ER) negativity (P<0.0005), progesterone receptor (PR) negativity (P=0.009), p53 expression (P=0.034), cytokeratin 5/6 positivity (P=0.008), epidermal growth factor receptor (EGFR) expression (P=0.015) and the BLP (P<0.0005), whereas it was inversely associated with BMI-1 staining (P=0.009). On the other hand, BMI-1 expression was associated with low histological grade (P=0.004) and ER positivity (P=0.001).
Conclusion: There was a high prevalence of ALDH1 expression among breast carcinomas and associations with basal markers and features of aggressive tumours. Studies are required to elucidate the importance of these findings for improved understanding of breast cancer biology.
Figures
Similar articles
-
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.Cancer Sci. 2009 Jun;100(6):1062-8. doi: 10.1111/j.1349-7006.2009.01151.x. Epub 2009 Mar 9. Cancer Sci. 2009. PMID: 19385968 Free PMC article.
-
Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.Cancer. 2013 Feb 1;119(3):488-94. doi: 10.1002/cncr.27737. Epub 2012 Aug 28. Cancer. 2013. PMID: 22930220 Free PMC article.
-
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb. Pathology. 2012. PMID: 22544210
-
Breast cancer stem cells and intrinsic subtypes: controversies rage on.Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. doi: 10.2174/157488809787169110. Curr Stem Cell Res Ther. 2009. PMID: 19149630 Review.
-
A review of the racial heterogeneity of breast cancer stem cells.Gene. 2021 Sep 5;796-797:145805. doi: 10.1016/j.gene.2021.145805. Epub 2021 Jun 29. Gene. 2021. PMID: 34197949 Review.
Cited by
-
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.Elife. 2021 Dec 10;10:e70729. doi: 10.7554/eLife.70729. Elife. 2021. PMID: 34889737 Free PMC article.
-
Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.Insights Imaging. 2023 Jul 21;14(1):133. doi: 10.1186/s13244-023-01474-x. Insights Imaging. 2023. PMID: 37477715 Free PMC article.
-
Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation.Strahlenther Onkol. 2017 Oct;193(10):848-855. doi: 10.1007/s00066-017-1165-2. Epub 2017 Jun 22. Strahlenther Onkol. 2017. PMID: 28642964 English.
-
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.Oncotarget. 2013 Aug;4(8):1293-308. doi: 10.18632/oncotarget.1136. Oncotarget. 2013. PMID: 23945276 Free PMC article.
-
Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations.Patholog Res Int. 2011 Jan 9;2011:806831. doi: 10.4061/2011/806831. Patholog Res Int. 2011. PMID: 21274453 Free PMC article.
References
-
- Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H (2005) Prevalence of CD44+/CD24−/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11: 1154–1159 - PubMed
-
- Alkema MJ, Wiegant J, Raap AK, Berns A, van Lohuizen M (1993) Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Genet 2: 1597–1603 - PubMed
-
- Arnes JB, Collett K, Akslen LA (2008) Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology 52: 370–380 - PubMed
-
- Bachmann IM, Puntervoll HE, Otte AP, Akslen LA (2008) Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol 21: 583–590 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
